Latest in Pharmacology and Impact to Cardiometabolic Disease: An AACVPR Webinar Series
- Registration Closed
This free webinar series, sponsored by Novo Nordisk Inc., is tailored to multidisciplinary cardiac rehabilitation professionals, and will consist of three, 60-minute live webinar presentations addressing weight management and guideline directed care in cardiovascular disease. Each live webinar will be recorded and offered on-demand in the AACVPR Learning Center.
By participating in this webinar series, attendees will be able to:
1. Describe the pathophysiological link between cardiometabolic disease and obesity.
2. Apply evidence-based strategies for enhancing cardiac rehabilitation adherence and reducing hospital readmissions.
3. Summarize the guideline-directed medical therapy in reducing and preventing major cardiovascular events and hospital readmissions.
4. Identify potential adverse effects of cardiovascular guideline-directed medical therapy.
Webinar Series Schedule:
May 8, 2025 | Noon-1:00 p.m. CT | #1: Uncovering the Connection Between Cardiovascular Disease and Obesity | Carl J. Lavie Jr., MD
June 17, 2025 | Noon-1:00 p.m. CT | #2: Empowering Cardiac Rehabilitation Patients for Cardiovascular Health | Megan Hays, PhD
July 14, 2025 | 1:00-2:00 p.m. CT | #3: Guideline Directed Therapy on the Reduction of Major Adverse Cardiovascular Events | Tracey Taveira, Pharm.D., CDOE, CVDOE
Recordings will be made available within 10 business days following each webinar. There is a 60-day viewing window for the recordings. This presentation series is sponsored by Novo Nordisk, Inc. This presentation is not offered for credits (CEUs).
